Schizophrenia Research
Volume 101, Issue 1 , Pages 256-265 , April 2008

Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes

  • Julie Kreyenbuhl

      Affiliations

    • Division of Services Research, Department of Psychiatry, University of Maryland School of Medicine, 737 W. Lombard Street, 5th floor, Baltimore, MD, 21201, United States
    • VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), 10 N. Greene St. (BT/MIRECC), Baltimore, MD, 21201, United States
    • Corresponding Author InformationCorresponding author. University of Maryland School of Medicine, Department of Psychiatry, Division of Services Research, 737 W. Lombard Street, 5th floor, Baltimore, MD 21201, United States. Tel.: +1 410 605 7466; fax: +1 410 605 7739.
    • ,
  • Deborah R. Medoff

      Affiliations

    • Division of Services Research, Department of Psychiatry, University of Maryland School of Medicine, 737 W. Lombard Street, 5th floor, Baltimore, MD, 21201, United States
    • VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), 10 N. Greene St. (BT/MIRECC), Baltimore, MD, 21201, United States
    • ,
  • Stephen L. Seliger

      Affiliations

    • Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, 22 S. Greene St., N3W143, Baltimore, MD, 21201, United States
    • ,
  • Lisa B. Dixon

      Affiliations

    • Division of Services Research, Department of Psychiatry, University of Maryland School of Medicine, 737 W. Lombard Street, 5th floor, Baltimore, MD, 21201, United States
    • VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), 10 N. Greene St. (BT/MIRECC), Baltimore, MD, 21201, United States

Received 6 November 2007 ,Revised 5 February 2008 ,Accepted 7 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-9964(08)00096-0

doi: 10.1016/j.schres.2008.02.004

Schizophrenia Research
Volume 101, Issue 1 , Pages 256-265 , April 2008

Article Tools

* Image Usage & Resolution